{"rows":[{"id":5909,"title":"Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives.","authors":"Vásquez-Bonilla JN.","journal":"Human psychopharmacology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/hup.70063","pubmed_id":"42693701","openalex_id":"https://openalex.org/W7208787084","source_url":"https://doi.org/10.1002/hup.70063","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Review Article,Case Report,Animal Study,Safety,Drug Interactions,Inflammation,Immune Function","study_type":"Clinical Trial","source_name":"Europe PMC","publication_status":"published","date_added":"2026-09-05 01:20:06","last_checked":"2026-09-08 01:20:16","bibtex":null,"source_record_id":"PMID:42693701","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1002/hup.70063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42693701","source_url":"https://doi.org/10.1002/hup.70063","doi":"10.1002/hup.70063","pmid":"42693701","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2734,"title":"Hallucinogenic drugs attenuate the subjective response to alcohol in humans.","authors":"Barrett SP, Archambault J, Engelberg MJ, Pihl RO","journal":"Human psychopharmacology","publication_date":"2000-10-01","publication_year":2000,"doi":"10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j","pubmed_id":"12404626","openalex_id":"https://openalex.org/W2005015693","source_url":"https://pubmed.ncbi.nlm.nih.gov/12404626/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Drug Interactions","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:30","bibtex":null,"source_record_id":"PMID:12404626","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/12404626/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:12404626","source_url":"https://pubmed.ncbi.nlm.nih.gov/12404626/","doi":"10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j","pmid":"12404626","publication_date":"2000-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2683,"title":"Patterns of simultaneous polysubstance use in drug using university students.","authors":"Barrett SP, Darredeau C, Pihl RO","journal":"Human psychopharmacology","publication_date":"2006-06-01","publication_year":2006,"doi":"10.1002/hup.766","pubmed_id":"16783813","openalex_id":"https://openalex.org/W2119461820","source_url":"https://pubmed.ncbi.nlm.nih.gov/16783813/","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:29","bibtex":null,"source_record_id":"PMID:16783813","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/16783813/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:16783813","source_url":"https://pubmed.ncbi.nlm.nih.gov/16783813/","doi":"10.1002/hup.766","pmid":"16783813","publication_date":"2006-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2603,"title":"Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.","authors":"Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM, Erritzoe D","journal":"Human psychopharmacology","publication_date":"2012-07-01","publication_year":2012,"doi":"10.1002/hup.2234","pubmed_id":"22696164","openalex_id":"https://openalex.org/W1948675593","source_url":"https://pubmed.ncbi.nlm.nih.gov/22696164/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:28","bibtex":null,"source_record_id":"PMID:22696164","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/22696164/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:22696164","source_url":"https://pubmed.ncbi.nlm.nih.gov/22696164/","doi":"10.1002/hup.2234","pmid":"22696164","publication_date":"2012-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2311,"title":"A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines.","authors":"Palamar JJ, Acosta P","journal":"Human psychopharmacology","publication_date":"2020-01-01","publication_year":2020,"doi":"10.1002/hup.2719","pubmed_id":"31909513","openalex_id":"https://openalex.org/W2999306893","source_url":"https://pubmed.ncbi.nlm.nih.gov/31909513/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:31909513","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31909513/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31909513","source_url":"https://pubmed.ncbi.nlm.nih.gov/31909513/","doi":"10.1002/hup.2719","pmid":"31909513","publication_date":"2020-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2251,"title":"Psilocybin occasioned mystical-type experiences.","authors":"James E, Robertshaw TL, Hoskins M, Sessa B","journal":"Human psychopharmacology","publication_date":"2020-09-01","publication_year":2020,"doi":"10.1002/hup.2742","pubmed_id":"32573835","openalex_id":"https://openalex.org/W3037497292","source_url":"https://pubmed.ncbi.nlm.nih.gov/32573835/","substance_tags":"psilocybin","topic_tags":"Mystical Experience,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:32573835","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/32573835/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:32573835","source_url":"https://pubmed.ncbi.nlm.nih.gov/32573835/","doi":"10.1002/hup.2742","pmid":"32573835","publication_date":"2020-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":347,"title":"Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.","authors":"Freitas da Costa B, Hartmann P, Pagnin D","journal":"Human psychopharmacology","publication_date":"2026-01-01","publication_year":2026,"doi":"10.1002/hup.70032","pubmed_id":"41502021","openalex_id":"https://openalex.org/W7118595574","source_url":"https://pubmed.ncbi.nlm.nih.gov/41502021/","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:53","bibtex":null,"source_record_id":"PMID:41502021","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41502021/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41502021","source_url":"https://pubmed.ncbi.nlm.nih.gov/41502021/","doi":"10.1002/hup.70032","pmid":"41502021","publication_date":"2026-01-01","importer_version":"2.1.3","text_redistributed":false}}],"total":7,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Human psychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}